€1m · Other round · Healthtech · Milan, Italy
Milan-based Doctorsa has raised €1m in its first external funding round, led by PranaVentures with participation from Vento and 40Jemz Ventures. According to Forbes Italia's report, the company will use the capital to consolidate existing markets, expand internationally and develop a B2B offer for travel operators, insurers and employers.
Urgent care for people outside their home system
Doctorsa connects travellers with doctors for video consultations, clinical guidance and, where appropriate and permitted, prescriptions. The service is designed for a moment when conventional access is unusually difficult: the patient may not speak the local language, understand the healthcare system or know whether an insurance helpline will provide timely care.
The platform operates without a prior subscription. A traveller describes the problem, selects an available doctor in the country they are visiting and starts a video consultation. The company says its network includes more than 550 doctors across 40 countries and that it has supported more than 250,000 travellers in three years. Those are company-reported figures, but they show the model moving beyond a single destination or domestic telemedicine service.
Distribution can shift from travellers to travel companies
Doctorsa's initial route is direct-to-consumer urgent care: a traveller pays when a medical need appears. The planned B2B offer changes the distribution mechanism. Tour operators, travel agencies, insurers and employers can embed access to Doctorsa into an existing trip, policy or benefits programme, putting the service in front of a traveller before the moment of need.
PranaVentures describes that offer as complementary to travel insurance and free for the distributing partner. That is the investor's thesis rather than a disclosed commercial contract, but it explains why the round is aimed at partnerships as well as geographic coverage. If distribution partners can add the service without rebuilding their own medical network, Doctorsa can reach many travellers through each integration. The execution burden shifts to service availability, clinical quality and reliable hand-offs across countries.
AI lowers booking friction but does not replace the doctor
Doctorsa has also developed an agentic booking interface that lets users request and book a consultation through an AI assistant while retaining final control over the booking. The useful role for automation is narrow: translate a user's intent into an appointment and reduce the steps between a health concern and a qualified clinician.
That distinction matters in healthcare. Faster booking can improve access, but the medical consultation, judgement and prescription remain with licensed doctors. Doctorsa therefore has to scale two connected systems: the software and partner integrations that generate demand, and the cross-border doctor network that fulfils it. The €1m round gives it capital to expand both, while the commercial test is whether partner-led distribution can grow without weakening response times or care quality.
